Delivery Order SPE2DR25D2003-SPE2DR26FR00W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) valued at $2,456.94. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,534.47. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by December 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Kerendia 10 mg tablets (30-count) under a firm fixed-price contract valued at $1,683.15. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The order is to be...
- The Defense Logistics Agency awarded a $1,914.67 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Kerendia 10 mg tablets (30-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicles with the...
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Kerendia 10 mg tablets in a 30-count package with a ceiling value of $14,581.71 under firm fixed pricing. This non-set-aside delivery order, due for completion by December 2, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract valued at $14,979.25. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $30,647.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (90-count units) on September 29, 2025, with an ultimate completion date of September 30, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR00WDelivery Order
The Defense Logistics Agency awarded a $46,258.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Kerendia 10 mg tablets (30-count units). The contract, designated as a non-set-aside competitive award, is scheduled for completion by December 5, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial role in federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems through the DLA Medical Supply Chain. The company's existing IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. This specific delivery order for Kerendia reflects the company's ongoing capability to fulfill federal pharmaceutical supply requirements through open competition and established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.3k | 12/3/25 |